Digital Genome Engineering: Unlocking the Potential of Synthetic Biology

Inscripta’s Symposium — January 2022

Synthetic biology is disrupting diverse markets from chemicals to food, cosmetics, materials, and therapeutics. Whether you’re a metabolic engineer optimizing lysine biosynthesis in E. coli or seeking to conduct a genome-wide functional genomics screen in yeast, Digital Genome Engineering is the key to unlocking the limitless applications of synthetic biology. Realizing the full potential of this game changing technology in your research requires accessing the latest tools, understanding industry trends, and learning from best practices of industry leaders.

In partnership with SynBioBeta, Inscripta® brought together synthetic biology thought leaders for an innovative symposium. The sessions featured perspectives from industry leaders, highlight the latest innovations in Digital Genome Engineering, and provide a vision for the future of SynBio.

Session 1: A Vision for Engineering Biology: Exploring Rational and Empirical Design Space

Session 2: Rapid Protein and Strain Improvement with Iterative Genome Engineering

Session 1 & 2: Q&A

Session 3: Customer Perspectives: What Will Be the Next SynBio Success Story?

A Vision for Engineering Biology: Exploring Rational and Empirical Design Space

Hear from the leading scientists developing the next generation of enabling technologies about what we have learned from decades of engineering biological systems and how can we apply this knowledge to accelerate SynBio innovation.

Speakers:

  • Patrick Westfall, Senior Director, Microbe, Inscripta
  • Richard Fox, CEO, CTO, and Co-founder, Infinome Bio

Moderator: Nandini Krishnamurthy, VP, Microbial Business Unit

Duration: 36 mins

Rapid Protein and Strain Improvement with Iterative Genome Engineering

The key to successfully engineering biological systems is enabling rapid diversity generation and recombining beneficial changes through iterative editing cycles. Learn how this approach can be applied to protein and strain engineering with automated Digital Genome Engineering.

Speaker: Eric Abbate, Director, Analytical Biochemistry, Inscripta

Duration: 30 min

Q&A

Q&A from sessions 1 and 2

Speakers:

  • Eric Abbate, Director, Analytical Biochemistry, Inscripta
  • Patrick Westfall, Senior Director, Microbe, Inscripta
  • Richard Fox, CEO, CTO, and Co-founder, Infinome Bio
  • Nandini Krishnamurthy, VP, Microbial Business Unit

Duration: 15 min

Customer Perspectives: What Will Be the Next SynBio Success Story?

SynBio pioneers have successfully brought new ingredients to market over the past decades through innovative approaches. Join a discussion with industry leaders to hear how they are incorporating new technologies to accelerate time to market and the outlook on the future of synthetic biology.

  • Andrew Horwitz, PhD, Vice President, R&D, Sestina Bio
  • Kirsten Benjamin, PhD, Vice President, R&D, Amyris
  • Bob Van Hove, PhD, Program Director, Ginkgo Bioworks

Moderator: Joseph Maffei and Lauren Neves, FAS, Inscripta

Duration: 1 hour